EUVIMEDOpdag EUVIMED
Systematische ÜbersichtMetaanalyseStudienprotokollOpen access

Effects of Oral Resveratrol Supplementation on Inflammatory and Cardiometabolic Outcomes in Adults: Protocol for a Systematic Review and Meta-Analysis

Andrea Herrera-Santelices, Josefa Camila Núñez Rivas, Francisca P Rubio-Molina, Ileana González Bonet

JMIR Research Protocols · 2026-10-27 · 15 · e101301-e101301

DOI: 10.2196/101301 ↗

At a glance

Systematische Übersicht in JMIR Research Protocols, published online on 2026-10-27. Written by Andrea Herrera-Santelices and 3 co-authors. Institution: Departamento de Ciencias Preclínicas, Facultad de Medicina, Universidad Católica del Maule, Avda San Miguel 3605, Talca, Maule, Chile, 56 712968000. Major MEDLINE topics: Resveratrol, Inflammation, Dietary Supplements. 31 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Resveratrol is a naturally occurring polyphenol found primarily in grapes, berries, peanuts, and red wine. Experimental evidence suggests that resveratrol modulates multiple biological pathways involved in oxidative stress, inflammation, insulin signaling, endothelial function, and metabolic homeostasis. However, findings from randomized controlled trials remain inconsistent, and previous evidence syntheses have reported substantial clinical and methodological heterogeneity.

Objective

This is a protocol for a systematic review and meta-analysis that will provide an updated synthesis of randomized controlled trials evaluating the effects of oral resveratrol supplementation on inflammatory biomarkers and cardiometabolic outcomes in adults while exploring potential methodological and biological sources of heterogeneity.

Methods

This protocol was developed according to the PRISMA-P (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols) statement and prospectively registered in PROSPERO. Randomized controlled trials comparing oral resveratrol supplementation with placebo, other nutritional supplements, or no intervention in adults will be eligible. Literature searches will be conducted in the PubMed, Cochrane CENTRAL, Scopus, Web of Science, and SciELO databases. Two reviewers will independently perform study selection, data extraction, and risk-of-bias assessment using the Cochrane risk of bias 2 tool. The certainty of evidence will be assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach.

Results

During peer review, the search strategy was refined before initiation of the formal review. As of August 2026, the formal systematic review had not yet commenced. The literature search and study selection are scheduled to begin on September 1, 2026, and the systematic review is expected to be completed by April 2027, with dissemination of the findings anticipated thereafter.

Conclusions

This systematic review and meta-analysis protocol is expected to provide an updated and transparent synthesis of the available randomized evidence regarding the effects of oral resveratrol supplementation on inflammatory biomarkers and cardiometabolic outcomes in adults.

Subjects

MeSH terms (MEDLINE)

ResveratrolInflammationDietary SupplementsHumansMeta-Analysis as TopicSystematic Reviews as TopicAdministration, OralAdultBiomarkers

Author keywords

cardiometabolic outcomesinflammatory biomarkersmeta-analysisrandomized controlled trialresveratrolsystematic review

Substances

ResveratrolBiomarkers

Authors and institutions

  • Departamento de Ciencias Preclínicas, Facultad de Medicina, Universidad Católica del Maule, Avda San Miguel 3605, Talca, Maule, Chile, 56 712968000.
  • Servicio de Medicina Física y Rehabilitación, Hospital San Juan de Dios de Curicó, Servicio de Salud del Maule, Curicó, Maule, Chile.
  • Carrera de Medicina, Facultad de Medicina, Universidad Católica del Maule, Talca, Maule, Chile.
  • Sistema de Bibliotecas, Universidad Católica del Maule, Talca, Maule, Chile.

Cite

APA

Herrera-Santelices, A., Núñez Rivas, J. C., Rubio-Molina, F. P., & González Bonet, I. (2026). Effects of Oral Resveratrol Supplementation on Inflammatory and Cardiometabolic Outcomes in Adults: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols, 15, e101301-e101301. https://doi.org/10.2196/101301

Vancouver

Herrera-Santelices A, Núñez Rivas JC, Rubio-Molina FP, González Bonet I. Effects of Oral Resveratrol Supplementation on Inflammatory and Cardiometabolic Outcomes in Adults: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols. 2026;15:e101301-e101301. doi:10.2196/101301

BibTeX
@article{HerreraSantelices2026,
  author = {Herrera-Santelices, Andrea and Núñez Rivas, Josefa Camila and Rubio-Molina, Francisca P and González Bonet, Ileana},
  title = {Effects of Oral Resveratrol Supplementation on Inflammatory and Cardiometabolic Outcomes in Adults: Protocol for a Systematic Review and Meta-Analysis},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e101301--e101301},
  doi = {10.2196/101301}
}
Start for free →